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Summary.-I.p. or i.v. administration of Corynebacterium parvum (CP) to MF1 mice
induces a generalized inflammatory response, associated with marked hepato-
splenomegaly and accompanied by a pronounced granulomatous response in the
liver. Injection of the Landschutz ascites carcinoma (LAC) 24 h after CP substantially
reduced the intensity of the inflammatory response, and decreased both thefrequency
and size of the hepatic granulomas, as revealed by morphometric analysis of histo-
logical sections.
The difference in cellular composition of the granulomas between the experi-
mental groups, as revealed by light microscopy, was further emphasized and
characterized by ultrastructural studies. These revealed the predominance of macro-
phages within the granulomas in tumour-bearing mice, in contrast to the predomin-
ance of epithelioid cells in the lesions which developed in mice given CP alone.
Our experimental findings show that the inhibitory effect of the growing LAC on
granuloma formation in response to CP cannot be ascribed to (a) sequestration of
the microorganism within the growing tumour, (b) a nonspecific inflammatory
stimulus, (c) diversion and seqestration of mononuclear phagocytes in the growing
tumour or (d) the presence of lactate dehydrogenase-elevating virus in either the
host or tumour cells. The inhibition of liver granuloma formation is consistent with
an effect mediated by soluble, heat-stable tumour-associated factor(s).
IT IS WELL RECOGNIZED that systemic
administration of Corynebacterium parvum
(CP) to laboratory animals causes marked
stimulation of the mononuclear phagocyte
system (MPS), characterized by con-
spicuous hepatosplenomegaly (Milas &
Scott, 1978). This is associated, in the
liver, with infiltration of lymphohistio-
cytic cells (Halpern et al., 1964; Milas
et al.; 1974; Brozovic et al., 1975) which
either form granulomas or diffusely in-
filtrate liver parenchyma (McBride et al.,
1974: Milas et al., 1974; Lampert et al.,
1977). Hepatomegaly is associated with
increased numbers andphagocytic activity
of Kupffer cells (Warr & Sljivic, 1974)
and in the spleen there is extensive pro-
liferation of macrophages, lymphocytes
and haemopoietic cells (Halpern et al.,
1964; Brozovic et al., 1975).
In a recent study, we found that
injection of Landschiitz ascites carcinoma
(LAC) cells substantially reduced the
increase in hepatic phagocytic activity
induced by CP (McIntosh et al., 1981).
Furthermore, in the same study we
found that after injection of the micro-
organism the incidence of granulomas
was markedly reduced in tumour-bearers.
We have now conducted further investiga-
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tions which reveal that tumour-carriage
not only reduces the incidence of CP-
induced granulomas, but also arrests
the normal sequence of morphological
changes within these lesions. We believe
that these results provide additional
evidence that malignant tumours exert
anti-inflammatory effects mediated by
humoral factor(s).
MATERIALS AND METHODS
Animals.-Closed-colony-bred female MFl
mice (mean wt 28 g) were used throughout.
They were bred in the University Animal
Department, Foresterhill, Aberdeen, main-
tained in a temperature-controlled environ-
ment and received Oxoid rat and mouse
breeding diet with tap water ad libitum.
Corynebacterium parvum.-Strain CN6134
was supplied by Wellcome Research Labora-
tories, Beckenham, as formalin-killed material
(Lot CA 761) at a concentration of 7 mg dry
weight washed CP per ml pyrogen-free
physiological saline, with 0.01% thiomersal
(phenylmercuric nitrate) as preservative.
The preparation was stored at 4°C, and mice
received 1-4 mg i.p. or 0 35 mg i.v. Controls
were injected with an equal volume of
Dulbecco "A" phosphate-buffered saline
(PBS).
Tumour.-The Landschuitz ascites carcino-
ma, a non-strain-specific subline of the
Ehrlich diploid carcinoma (Tjio & Levan,
1954) was propagated by i.p. injection of
0-2 ml undiluted cell suspension obtained by
peritoneal aspiration on the 7th day of
tumour development. The total number of
cellsinjected was 18-4 + 1 8 x 106andviability,
estimated by trypan-blue dye exclusion,
always exceeded 97%.
Preparation of liver cells.-Liver tissue
from normal MF1 mice was homogenized for
20 min at 37TC in 0.25% v/w pancreatic
trypsin (Difco Laboratories, West Molesey)
in PBS. The cells were then filtered through
stainless-steel gauze, washed in Eagle's
minimal essential medium (MEM, Wellcome)
and the concentration adjusted to 90 x 106/ml.
Each animal received 0-2 ml i.p.
Cell-free ascites fluid.-Peritoneal fluid was
collected from ascitic mice 11 days after
tumour injection and centrifuged for 30 min
at 12,000 g (Normann, 1978). The cell-free
supernatant was stored at -20°C and
thawed just before use. The protein concen-
tration, estimated by the Lowry method was
22-2 mg/ml and mice received 0.5 ml i.p.
Histology.-Livers and spleens were fixed
in 10% neutral buffered formalin. Paraffin
sections were cut at 5 ,um and stained with
haematoxylin and eosin (H. & E.). Gram
and Twort stains were used to identify CP
within the tissues. Mitotic incidence was
estimated under a x 10 objective.
Morphometric analysis of liver granulomas.
-Areas of parenchymal and perivascular
(periportal and pericentral vein) granulomas
in H. & E. sections of liver were estimated
after the method of Deimann & Fahimi
(1980). The GDS1 image-analysis system
(Graphics Information Systems, Blairgowrie)
was used, together with a Leitz Orthoplan
light microscope (Leitz Wetzlar, West Ger-
many). Ten randomly selected fields from
each section were projected on to a digitizing
pad, and the areas of the granulomas were
outlined on the graphic tablet which was
interfaced to a Tektronix 4051 computer.
The results were expressed as ratios of
granuloma volume to total liver volume.
The latter consisted of the volume of paren-
chymal and nonparenchymal cells as well
as sinusoids, portal triads and central veins,
but excluded larger vessels.
Electron microscopy.-For transmission
electron microscopy (TEM) tissue blocks
(1 mm3) were fixed for 4 h at 20CC in 2.5%
glutaraldehyde in 01M cacodylate buffer,
containing 2-5mM CaCl2. After post-fixation
in 1% osmium tetroxide the tissue was
dehydrated and embedded in TAAB epoxy
resin. Ultrathin sections were stained with
uranyl acetate and lead citrate before
examination in an AEI EM6B transmission
electron microscope.
Morphological characterization of peritoneal
cells.-Peritoneal cavities were lavaged with
MEM containing 2i.u. heparin (Duncan,
Flockhart and Co., London) per ml. One-ml
aliquots of washed cells from each of 5 mice
were pooled, and replicate counts (each
based on at least 200 cells) of the different
cell types were made on Romanowsky-
stained (Haema-Tek system; Miles Labora-
tories, Slough) cytospin preparations. The
tumour cells were identified as large mono-
nuclear (occasionally multinucleate) forms,
with a large eccentric nucleus with prominent
dense clumps of chromatin. The other
characteristic feature (Hughes & Dodds, 1968)
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was a prominent pale-staining Golgi region
adjacent to the nucleus and associated with
numerous granules and vacuoles.
Assayfor LDH.-Individual blood samples
were collected from normal and tumour-
bearing mice by cardiac puncture, and the
serum obtained w%as then assayed for lactate
dehydrogenase (LDH) activity. The
pyruvate-dependent oxidation of reduced
nicotinamide-adenine dinucleotide was mea-
sured at 27°C at 340 nm on a recording UV
spectrophotometer, essentially by the method
of Rowson & Mahy (1975). The serum LDH
activity was calculated by
LDH ( U/ 1) AE/min
LH(mU/ml)
= 6-22 x 103 X Ml sample used
Statisctics.-The significance of differences
between means was established using a 2-
tailed t test for unpaired samples.
RESULTS
Injection of viable tumour 24 h after
CP significantly suppressed (P < 0 005)
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FIG. 1. (a) LivTer and (b) spleeni weights of
mice 8 days after i.p. C. parvum. The
additional injections were given i.p. 24 h
after the microorganism. Also shown are
organ weights in mice given tumour
alone. Results are means + s.d. for 4-9
mice. HK tumour=heat-killed (18 x 106
cells heated at 560 for 30 min); Tumour
fluid= 0 5 ml 11-day cell-free ascitic fluid;
TBS= 0-5 ml pooled 11-day tumour-bearer
serum; NMS =05 ml pooled normal
mouse serum.
the marked hepatosplenomegaly evident
8 days after i.p. administration of the
microorganism (Fig. 1). No such inhibition
was seen in animals given heat-killed
tumour-cell suspension, ascitic fluid,
tumour-bearer (TBS) or normal mouse
serum (NMS). Indeed, ascitic fluid and
NMS caused a small but significant
increase (P < 0-05) in liver weight over
that produced by CP.
Morphometric analysis of the livers
revealed that in tumour-bearing animals
there was a very striking reduction in the
degree ofgranuloma formation in response
to CP (Fig. 2). In mice given CP alone,
about 15% of the total parenchymal
volume at 8 days was occupied by
granuloma tissue, of which 24% was
perivascular granuloma. The injection of
viable or heat-killed tumour, ascitic fluid
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Fia. 2. Volume of liver granulomas 8 days
after i.p. C. parvum, estimated by image
analysis. The additional injections were
given i.p. 24 h after the microorganism.
Results are means + s.d. for 4-6 mice.
Abbreviations as in Fig. 1.
or TBS significantly depressed (P < 0.005)
both parenchymal and perivascular granu-
loma production. No significant effect was
obtained with NMS. A striking change
was also noted in the morphological
characteristics of the granulomas in the
tumour-bearers; instead of containing
"epithelioid" cells as seen in response to
CP alone, they contained predominantly
mononuclear cells (Fig. 3).
TEM revealed that those liver granu-
lomas which developed in the mice
injected with CP and tumour cells con-
tained small monocytes 10-14 zm in
diameter, which resembled circulating
blood monocytes, and larger cells 14-20
,tm in diameter, with ultrastructural
features resembling those of tissue mono-
cytes (see Carr, 1973). Although both
types of cells contained mitochondria,
endoplasmic reticulum, lysosomes and
40
Golgi apparatus, there was hypertrophy
of the Golgi apparatus within the larger
tissue monocytes and an increase in the
number oflysosomes. In those granulomas
developing within the mice injected with
CP alone, there were epithelioid cells in
addition to monocytic cells. The epithe-
lioid cells contained mitochondria, 5 nm-
diameter microfilaments, active Golgi ap-
paratus, endoplasmic reticulum, lysosomes
and vacuoles containing flocculates of
moderately electron-dense material. The
plasma membranes of the epithelioid cells
were thrown into numerous villiform
processes, and there was extensive inter-
digitation of adjacent epithelioid-cell
plasma membranes, forming a reticular
pattern (Fig. 4). However, no structures
resembling desmosomes were found
between the contiguous membranes of
adjacent epithelioid cells.
Examination of Gram- and Twort-
stained sections of liver and spleen
revealed that the tumour did not affect
the uptake or distribution of CP within
mononuclear phagocytes. However, the
tumour did cause a marked reduction
(- 60%) in the increased incidence of
mitotic figures within the liver paren-
chyma in response to CP. This inhibition
was reduced with heat-killed tumour,
ascitic fluid and TBS, but was not seen
in response to NMS.
Additional studies were conducted to
examine the specificity of this apparent
inhibition by LAC of the granulomatous
response to CP. In order to establish that
the tumour was not acting simply as a
diversionary stimulus for cells which
might otherwise populate the liver in
response to CP, absolute and differential
counts of host cells within the peritoneum
were made. It is clear from these results
(Fig. 5) that injection of LAC 24 h after
CP caused no further significant increase
in the absolute numbers of lymphocytes,
macrophages or granulocytes. Indeed,
macrophage numbers were quite strikingly
depressed after tumour injection, especi-
ally in the CP group. In the spleen, the
pronounced increase in macrophage
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FIG. 3.-Liver sections (a) 8 days after i.p. CP, showing pronounced parenchymal and perivascular
granulomas; (b) shows their epithelioid nature; (c) 8 days after CP and 7 days after tumour,
showing reduction in granuloma volume and (d) their "lymphohistiocytic" nature. All H. & E.;
(a) and (c) x 120, (b) and (d) x 300.
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FIG. 4.-(a) Electron micrograph showing epithelioid cells within a CP-induced granuloma. The
plasma membranes of the epithelioid cells are thrown into slender villiform processes, and there
is characteristic extensive interdigitation of the plasma membranes of adjacent cells ( x 9500).
(b) Electron micrograph of granuloma in mouse given CP 8 days and tumour 7 days previously,
showing a small monocyte and the larger tissue monocyte. Whereas both cells contain lysosomes,
the latter cell contains a more active Golgi apparatus ( x 6000). (c) The predominant cells within
the granuloma are tissue macrophages containing prominent lysosomes. ( x 9500).
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FiG. 5. Absolute lymplhocyte (*), monocyte (*) an(t grainulocyte (c2) counts witlin the peIitoineal
Casities at various times after injeetion of ttumour, C'P + ttumour an(l CP alonie. Each point represents
thie result from 5 animals.
ntimbers seen in the marginal zones in
response to CP was absent from mice
which also received tumour (Fig. 6).
The inhibitory effects of i.p. tumour
given 24 h after CP, were also seen in
mice given the microorganism by the i.v.
route (Table I). In addition to inhibition
of CP-induced hepatosplenomegaly, over-
all granuloma production was reduced by
870%, with a more marked effect on
parenchymal than perivascular granu-
lomas. Injection of the tumour 3 days
before CP (i.p. or i.v.) had similar effects
on organ weights, and either totally
eliminated the granulomatous response
(i.p. injection) or reduced it by 57%0
(i.v. route) (Table II).
A potent inflammatory stimulus
(sodium caseinate) given once by the i.p.
route 24 h after CP did not affect the
increase in organ weights, but did signifi-
cantly inhibit (by 38%) granuloma pro-
(luction (Table III). This effect was
considerably less than the 87% inhibition
induced by tumour under similar con-
ditions (see Fig. 2 and Table I) and was
not significantly enhanced by repeated
injection of the caseinate. Moreover,
sodium caseinate did not impair the
progression to "epithelioid" granulomas.
Injection of an equal number of viable
normal liver cells did not, in contrast to
tumour cells, significantly reduce either
CP-induced hepatosplenomegaly or granu-
loma production (Table IV).
There was no significant difference
between the plasma and serum levels of
LDH activity found in control animals,
so the levels in experimental animals
were expressed in terms of serum activity
(Table V). A 5-fold increase in this level
was obtained 2 days after injection of
viable tumour, rising to 15-fold by Day
4 (when the tumour mass becomes
measurable). This level was maintained
over the next 7 days (i.e. Day 11 not
significantly different from Day 4, though
Day 7 was lower, P < 0 01).
DISCUSSION
There is substantial evidence that the
various activities of the MPS are affected
during the course of tumour growth in
experimental animals (James, 1977; North
et al., 1978: Nelson et al., 1981). Whereas
in some instances tumours appear to
have an enhancing effect on MPS responses
(Nelson & Kearney, 1976; Meltzer &
Stevenson, 1978), in other cases a depres-
sive effect has been reported (Eccles &
Alexander, 1974; Pike & Snyderman,
1.976: Nelson & Nelson, 1978; Johnson
et al., 1978: Normann & Cornelius, 1978:
Tumour
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FIG. 6.-Spleen (a) 8 days after i.p. CP, showing pronounced increase in marginal zone
macrophages; (b) 8 days after CP and 7 days after tumour, showing absence of this response
H.&E. x120.
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TABLE I.-Effect of tumour on granuloma production induced by i.v. C. parvum
Treatment
Control (normal)
Tumour
CP
CP+tumour (Day 1)
Organ weight
(g/25 g body wt)
C- C--
Liver Spleen
1-45+0-11 0-09+0-02
1-78+0-24 0-21+0-08**
2*37+0-32 0-29+0-10
1.80+0-22* 0-19+0-06
Volume of granulomas
(% liver tissue)
Parenchymal Perivascular
0
0
7-51+ 2-30
0-68+0-44**
0
0
2-78+0-78
0-68+0-44**
Results are means + s.d. for 4-6 mice, 8 days after CP injection. Tumour was injected i.p. 24 h after CP.
Asterisks indicate significance of difference from corresponding (adjacent) controls: * P < 0 02;
**P<0 005.
TABLE II.-Effect of tumour injection before CP on granuloma production
Organ weight
(g/25 g body wt)
11
Treatment
Control
Tumour (Day-3)
CP (i.p.)
Tumour (Day-3) +CP (i.p.)
CP (i.v.)
Tumour (Day- 3) +CP (i.v.)
Liver
1-45+0-14
1-95+0-28
2 52+0-22
1 *11+0.10**
2-37+0-32
1-91+0 22*
Spleen
0-12+ 0-02
0-11+0-03
0 44+0*07
0.09+0-02**
0-29+0-10
0-21 +0-06
Volume ofgranulomas
(% liver tissue)
Parenchymal Perivascular
0
0
11-85+ 1 75
0
7-51+2-30
3-23+2-51*
0
0
3-63+0-75
0
2-78+0-78
1 -78+0-78
C. parvum injected i.p. or i.v. on Day 0.
Results are means + s.d. on Day 8.
Asterisks indicate significance of difference from corresponding (adjacent) controls: * P < 0 02;
**P<0 005.
TABLE III.-Effect of an inflammatory stimulus (sodium caseinate) on CP-induced
1/11~~~~~~~~~~Vlueo rauoa
Treatment
Normal
CP+saline (Day 1)
CP+Na cas. (Day 1)
CP+saline (Days 1, 3, 5)
CP+Na cas. (Days 1, 3, 5)
granuloma production
Organ weight
(g/25 g body wt)
- A)
Liver Spleen
1-71+0-31 0-12+0-04
2-52+0-22 0*44+0*07
2-20+0-20 0-40+0-06
3 03+0.55 0-42+0-10
2-64+0-23 0-32+0-11
Volume ofgranulomas (0% liver tissue)
Parenchymal Perivascular
0
11-84+ 1-80
7-64+1.04**
8-81 +4-77
4 - 89 + 2 -53
0
3-67+0-58
2-03+0-45**
3-82+ 1-02
1-49+ 1-05*
Values are means + s.d. on Day 8.
Na cas.=sodium caseinate (0 5 ml 3-55% in PBS i.p.).
CP injected i.p.
Asterisks indicate significance of difference from corresponding (adjacent) controls: * P < 0-01;
**P<0 005.
TABLE IV.-Effect of liver cell injection on CP-induced granuloma production
ell ~~ ~ ~ ~ ~ ~ ~ Voueo gauoa
Organ weight
(g/25 g body wt)
Treatment Liver Spleen
Control 1- 71+ 0-31 0-12 +0*04
Livercells 1-81+0-15 0-14+ 0 02
CP 2-52+0-22 0 44+0 07
CP+liver cells 3.00+0.44* 0-37 + 0-06
Parer
Volume ofgranulomas
(% liver tissue)
ichymal Privascula
nehymal Perivascular
0
0
11-84+ 1-80
9-63+2-28
0
0
3-67+0-58
2-78+ 1-03
CP given i.p.
Values are means + s.d. for 4-6 mice on Day 8.
Liver cells were injected i.p. 24 h after CP.
Asterisk indicates significance of difference from corresponding (adjacent) control: * P < 0*05.
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TABLE V.-Effect of tumour on serum
LDH activity
Treatment LDH activity (mU/ml)
Control (normal)
Tumour (Day 2)
(Day 4)
(Day 7)
(Day 11)
309 + 119*
1685 + 407
4097 + 1410
2823 + 247
5116 + 858
Values are means + 1 s.d. obtained from groups of
6-10 mice.
* Plasma level: 374 + 392.
Normann et al., 1979; Cheung et al., 1979;
Cianciolo et al., 1980a, b). In this study, we
substantiate our previous finding (Mc-
Intosh et al., 1981) that the granulomatous
inflammatory response to CP, is impaired
by injection of LAC cells.
Systemic CP is associated with hepato-
splenomegaly and the infiltration of
inflammatory cells into a number of
organs, including the liver and spleen
(Milas & Scott, 1978). These tissues then
show a characteristic granulomatous res-
ponse (see e.g. Adams, 1976) with the
transformation of recruited blood mono-
cytes into tissue monocytes and epithe-
lioid cells. This response was confirmed
in the present study by the development
of lymphohistiocytic and epithelioid gran-
ulomas 5 days after i.p. CP injection;
only the latter type were evident by Day
8. No giant cells were found, in contrast
to the observation of Brozovic et al.
(1975) that giant cells of the Langhans
type appeared in addition to epithelioid
cells within CP-induced granulomas in rat
liver and spleen.
Injection of tumour 24 h after the
microorganism produced both a decrease
in the frequency and size of granulomas
and a significant difference in their
cellular composition. In tumour-bearers,
the lymphohistiocytic lesions observed
at Day 8 resembled those seen at an
earlier stage (Day 5) in animals given
CP alone. Our results suggest that the
presence of tumour alters the usual
progression ofthe granulomatous response
to CP and imply impairment of both cell
recruitment and transformation of histio-
cytes to epithelioid cells.
In CP-treated mice bearing tumour, a
decrease in liver and spleen weight was
also found. Hepatosplenomegaly is deter-
mined by the amount of CP entering the
tissues (Scott & Milas, 1977). Although it
is conceivable that some of the CP
administered by the i.p. route could have
been sequestered within i.p. tumour given
24 h after the microorganism, the LAC
cells are not phagocytic, and we have
never seen CP within them. Furthermore,
24 h is considered to be sufficient time for
i.p. CP to accumulate in the liver and
spleen. When total organ recovery rates
for 1251-labelled CP given i.p. or i.v.
were compared (Scott & Milas, 1977;
Dimitrov et al., 1977) it was found that
the highest recovery rates were obtained
from i.v. CP. Thesefindings implydifferent
processing of CP after i.p. and i.v. injec-
tion. It is possible that peritoneal macro-
phages could modify the processing of
CP after i.p. administration (Dimitrov
et al., 1977) since these cells do take up
the microorganism (Pugh-Humphreys &
Thomson, 1979; Scott & Milas, 1977).
Therefore, i.v. injection greatly reduces
the possibility of CP being sequestered
within the site of tumour growth, due
to lack of direct contact with cells in the
peritoneum. Our arguments are further
strengthened therefore by similar results
obtained with i.v. CP. Thus the decrease
in hepatosplenomegaly in response to i.v.
CP given 24 h before tumour can hardly
be explained in terms oflack ofavailability
ofthe microorganism. Indeed, 5 days after
its i.p. administration CP could easily be
seen within livers of tumour-bearing
mice.
The characteristic hepatosplenomegaly
was decreased only by the presence of
viable tumour. Other agents (heat-killed
LAC, ascitic fluid, TBS) whilst causing a
similar decrease in the inflammatory
response in these organs, did not affect
organ weights. It has been found (Fisher
et al., 1979) that the increase in weight of
rat livers is attributable not only to the
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lymphohistiocytic infiltrate which occurs
in response to the microorganism, but
also t,o hepatocyte proliferation. How-
ever, in our study, histological examina-
tion of those livers showing a reduced
granulomatous response also revealed a
decrease in parenchymal mitosis. Thus
the weight changes are not directly
related to the extent of granuloma forma-
tion or hepatocyte proliferation, but
could be due to increased water content
or an increased presence of intracellular
hepatic fat or glycogen (Fisher et al.,
1979).
A strong chemotactic factor is associa-
ted with CP (Wilkinson et al., 1973) and
mobilizes mononuclear cells into the
liver and spleen. Although in the present
study CP was seen in phagocytic cells
within livers and spleens of both normal
and tumour-bearing mice, there was a
marked reduction in the intensity of
the mononuclear-cell infiltrates in animals
bearing LAC. The decrease in hepatic
and splenic infiltrates could be accounted
for by a diversionary effect of i.p. tumour
on cell migration into these organs, to
decreased production of these cells in the
marrow, to impairment of chemotaxis,
or to a combination of these.
A number of different types of host
cell invade the Ehrlich ascites tumour
(EAT) (Lala, 1974) of which the LAC is
a subline. These include mononuclear
cells selectively recruited from the blood
and ultimately derived largely from the
marrow (Lala, 1974, 1976). From our
data it is clear that during the first 3
days of tumour growth there was a depres-
sion of absolute monocyte numbers within
the tumour; these were gradually restored
to normal from Day 4 onwards. In mice
given CP alone, there was only a very
short, transient depression, followed by
a rapid rise. In contrast, CP-treated
mice given tumour showed a sustained
depression of monocyte infiltration into
the tumour. This effect coincided with
decreased monocyte infiltration into the
livers and spleens of these animals. It is
hardly likely, therefore, that the tumour
acts simply by diverting inflammatory
cells which w%ould otherwise have colonized
the liver and spleen. In tumour-bearing
mice, PMN infiltration was unaffected in
accordance with the findings of others
(Snyderman & Pike, 1976; Normann &
Sorkin, 1977) that, whilst tumours inhibit
macrophage accumulation in vivo, they
have little such effect on PMN leucocytes.
Our data do not allow us to ascertain
whether impairment of chemotaxis or
monocytopoiesis cause the observed anti-
inflammatory effect of the tumour. In-
deed, both mechanisms could be acting.
We nevertheless favour the latter explana-
tion, since there were no large accumula-
tions of monocytes in the three major
lymphoreticular sites examined and,
furthermore, additional investigations (to
be reported) have not revealed substantial
numbers of these cells in the circulation.
Granuloma formation has been shown
to be sensitive to "counter-irritation"
(Cygielman & Robson, 1963; Goldstein
et al., 1967; Hicks, 1969; Robinson &
Robson, 1964,) the process whereby in-
flammation due to an inert irritant at
one site results in the production not only
of inflammatory mediators but also endo-
genous (host-derived) anti-inflammatorvy
factors which are carried via the blood
stream and can suppress inflammation
leading to granuloma formation at another
site (Atkinson & Hicks, 1975; Bonta,
1978). The failure of single or repeated
injections of a potent inflammatory stimii-
lus (sodium caseinate) to depress granu-
loma formation within the livers com-
parable to that of the LAC further sub-
stantiates our view that the tumour
is not actinig as a nonspecific inflammatory
stimulus, and thus is not acting simply as a
"counter-irritant". Since the injection of
normal viable mouse liver cells did not
affect the granulomatous response to CP
the effect oftumour is presumably specific,
and not simply due to the introduction of
viable cells into the peritoneum.
Many abnormalities in immune func-
tion, including suppression in macro-
phage fuinction, occur in mice infected
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with viruses (Specter & Friedmain, 1978;
Nelson et al., 1981). In particular lactate-
dehydrogenase-elevating virus (LDV) is
known to be widely distributed in labora-
tory mice (Riley et al., 1978) and is
associated with a nuimber of transplant-
able murine tumours (Riley, 1968). Since
virus-like particles have been observed
inside the LAC cells used in this study,
we have had to consider the possibility
that these are LDV and, further, that
both the anti-inflammatory effects and
the raised serum-LDH levels detecte(d
within the LAC tumour-bearing mice may
simply reflect LDV activity. The following
observations argue against this possibility.
Firstly, the virus-like particles observed
within the LAC cells were confined to these
tumour cells and, uinlike LDV, which
rapidly infects and replicates inside macro-
phages (Rowson & Mahy, 1975), they
were not seen in macrophages either in
the peritoneal cavity itself or in the
liver or in any of the lymphoretictular
organs examined (spleen, thymus and
lymph nodes) in both the normal and
LAC-bearing mice used in this study.
The particles seen within the LAC cells
closely- resembled typical C-type virus
particles. Both their ultrastructural ap-
pearance and mode of replication inside
the tumour cells will be the subject of a
further communication (Pugh-Humph-
reys, in preparation).
Secondly, our measurements of the
serum levels of LDV within untreated
and LAC injected mice were consistently
well belowr those commonly detected in
LDV-infected animals (Riley, 1.968). OuI
control value of <500 mU/ml demon-
strated the absence of LDV infection in
the untreated mice (Rowson & Mahy,
1975). The higher values found within the
LAC-bearing mice were not comparable
to those reported from LDV-infected
tumour-bearing animals in which, due to
synergism between the virus and tumour,
50-fold (Riley & lro6blewski, 1960) or
even 100-fold (Notkins, 1971) values above
normal are expected, once the tumour
mass has become measurable. Our observa-
tioIn of a 15-fold inicrease in LDH activity,
not rising above this level 7 days after
detectable growth of the LAC, was nearer
to the 8-10-fold increase observed in
uninfected tumour-bearing mice (Notkins,
1965). Furthermore, it must beemphasized
that supra-normal levels of plasma LDH
do not necessarily indicate LDV infec-
tion per se, since raised levels are a
common finding in tumour-bearing hosts
even where LDV infection can be definitely
ruled out (Riley, 1968). We believe that
the high serum LDH levels in our LAC-
bearing mice reflect( degeneration of host
inflammatory cells, in particular neutro-
phils, and death of LAC cells by apoptosis
(Wyllie et al., 1980) which has been seen
within the rapidly growing LAC tumour
(Pugh-Humphreys, in preparation).
Thirdly, unlike LDV, which does not
persist within cells maintained in culture
(Rowson & Mahy, 1975), the virus-like
particles seen withini the LAC cells were
retained even after prolonged subcultur-
ing.
Thus we do( not consider that LDV
contamination accounts for the observed
reduction in the inflammatory response
in LAC-inijected mice. It is interesting
to note in this context that Snyderman &
Cianciolo (1979) have shown that murine
tumours free of LDV produce an inhibitor
of macrophage accumulation in vivo. The
possible involvement of viral products in
the system, currently under our investiga-
tion, does not detract from the importance
of changes in macrophage function in
malignant disease.
The depression of granuloma formation
by a single injection of heat-killed LAC
cells indicates the presence of a heat-
stable tumour-associated factor in
sufficient quantity to cause macrophage
suppression. Heat-stable tumour-associa-
ted macrophage modulators have beeii
described by others (Saito & Tomioka,
1980; Pike & Snyderman, 1976). The
fact that the effects of LAC are also
found after injection of cell-free ascitic
fluid or TBS (but not NMS) provides
additional strong evidence that such a
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factor is released in LAC-injected mice.
Systemic distribution of the suppressive
factor(s) would account for the elimina-
tion or significant impairment of the
granulomatous inflammatory response to
CP when the tumour was administered
before the microorganism.
Previous workers have shown that
malignant tumour cells can subvert the
anti-tumour activities of phagocytic cells
by a rapid systemic suppression of
macrophage function, mediated by a
low-mol.-wt tumour-derived factor (North
et al., 1976). It has been demonstrated
that such a factor reduces the rate of
emigration of macrophages into inflam-
matory exudates (Snyderman et al., 1976),
can inhibit the development of macro-
phage colonies in marrow (Otu et al.,
1977) and impairs chemotaxis (Pike &
Snyderman, 1976). Indeed, there is con-
vincing evidence (Mahoney & Leighton,
1962; Bernstein et al., 1972; Fauve et al.,
1974) that tumour-bearing animals have
a general impaired capacity to mount
inflammatory responses.
Functional studies are currently being
undertaken to determine whether the
inhibition observed in this study is
exerted via direct interaction with mono-
cytes, or on host-derived soluble products
which affect these cells. Isolation and
biochemical characterization of the fac-
tor(s) are also currently under investiga-
tion.
We are grateful to Dr P. H. Whiting of the
Department of Chemical Pathology, Aberdeen, for
his advice on the enzyme assay. We also thank Mr
J. I. Milton and Miss M. Allardyce for skilled
technical assistance, the staff of the Animal Depart-
ment, Foresterhill, Aberdeen and the Department
of Medical Illustration, and Miss A. H. Mackay for
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